Study at v1.0.0
NCT00041678
159d526d234af18e3a34714230e7d1937301d5d9320551c4e879e4b16276ad90 · where else it appears
Data
{
"briefSummary": "The purpose of this study is to learn if aripiprazole is safe and effective in the treatment of psychosis associated with dementia of the Alzheimer's type.",
"completionDate": "2003-03",
"conditions": [
"Alzheimer Disease"
],
"enrollmentCount": null,
"enrollmentType": null,
"nctId": "NCT00041678",
"phase": "PHASE3",
"sponsorId": "otsuka-pharmaceutical-development-commercialization-inc",
"startDate": "2000-01",
"status": "COMPLETED",
"studyType": "INTERVENTIONAL",
"title": "Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type",
"url": "https://clinicaltrials.gov/study/NCT00041678"
}History in this collection
- addedv1.0.0Jun 12, 2026this version